An AI-guided tissue-engineering platform that grows human micro-tissues and models their responses to support drug research and development.
Quiet Capital
Activity from announced rounds
- Rounds participated in
- 10
- Confirmed lead rounds
- 1 8 roles undisclosed
- New companies
- 10 First participation on record · 0 follow-on
- Funding in participating rounds
- $756M 10 disclosed · full round size, not this investor’s share
By stage
By primary sector
2 more
By country
Rounds
10 in this selectionA health-benefits platform that lets employers set healthcare budgets while employees choose insurance and eligible care to fit their needs.
Dev cloud platform for validating and testing AI-driven software engineering
AI-native platform automating inventory, pricing and other critical decisions for spare parts businesses
Arch helps investors, advisers and family offices administer private-market portfolios by collecting documents, standardizing data and coordinating investment workflows.
Provides AI-powered patient journey platform for healthcare organizations
Equips ships with sensor packages and analytics to create a distributed real-time maritime intelligence network
Powers AI-native law firms with outcomes-based fixed pricing and predictable quality
Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases
Developing lifespan extension drugs for dogs